| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/04/2003 | CA2479812A1 Glutaminyl based dpiv inhibitors |
| 09/04/2003 | CA2477558A1 N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 09/04/2003 | CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1 |
| 09/04/2003 | CA2477309A1 Screening process |
| 09/04/2003 | CA2477283A1 Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes |
| 09/04/2003 | CA2477249A1 Novel type-1 cytokine receptor glm-r |
| 09/04/2003 | CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 09/04/2003 | CA2477008A1 Substituted pyrimidinones and pyrimidinthiones |
| 09/04/2003 | CA2476994A1 Methods of extending corneal graft survival |
| 09/04/2003 | CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 09/04/2003 | CA2476776A1 Reagents and treatment methods for autoimmune diseases |
| 09/04/2003 | CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof |
| 09/04/2003 | CA2476518A1 Compositions and methods for the treatment of immune related diseases |
| 09/04/2003 | CA2476173A1 Arylsulfone derivatives |
| 09/04/2003 | CA2475509A1 Treatment methods using anti-cd22 antibodies |
| 09/03/2003 | EP1340811A2 Antibodies with specificity for multiple adhesion molecules |
| 09/03/2003 | EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/03/2003 | EP1340505A2 Therapeutic use of cis-element decoys in vivo |
| 09/03/2003 | EP1340493A1 Solid support for extemporaneous homeopathic medicine |
| 09/03/2003 | EP1339854A2 Lipid metabolism enzymes |
| 09/03/2003 | EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof |
| 09/03/2003 | EP1339834A2 Enzymes |
| 09/03/2003 | EP1339751A2 Recombinant antibody fragments as autoantibody antagonists |
| 09/03/2003 | EP1339748A2 G-protein coupled receptors |
| 09/03/2003 | EP1339745A1 Immunotherapeutic methods and molecules |
| 09/03/2003 | EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/03/2003 | EP1339721A2 Hydroxyesters of 7-desmethylrapamycin |
| 09/03/2003 | EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/03/2003 | EP1339715A2 Heterocyclic ether substituted imidazoquinolines |
| 09/03/2003 | EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 09/03/2003 | EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 09/03/2003 | EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 09/03/2003 | EP1339708A2 Indole-type inhibitors of p38 kinase |
| 09/03/2003 | EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 09/03/2003 | EP1339691A1 Novel compounds |
| 09/03/2003 | EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 09/03/2003 | EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 09/03/2003 | EP1339662A1 Novel estrogen receptor ligands and methods iii |
| 09/03/2003 | EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 09/03/2003 | EP1339438A2 Methods for preventing transplant rejection in the eye |
| 09/03/2003 | EP1339427A2 Method of producing biospecific molecules by protein trans-splicing |
| 09/03/2003 | EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 09/03/2003 | EP1339422A2 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 09/03/2003 | EP1339420A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 09/03/2003 | EP1339415A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 09/03/2003 | EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines |
| 09/03/2003 | EP1339405A1 Use of anti-muscarinic agents and calcium channel blockers in combination |
| 09/03/2003 | EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 09/03/2003 | EP1339349A2 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 09/03/2003 | EP1339294A1 Nutritional composition for an immune condition |
| 09/03/2003 | EP1196414B1 Prodrugs of carbamate inhibitors of impdh |
| 09/03/2003 | EP1140048B1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases |
| 09/03/2003 | EP1077947B1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 09/03/2003 | EP0977741B1 Substituted phenyl derivatives, their preparation and use |
| 09/03/2003 | EP0929533B1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same |
| 09/03/2003 | EP0868182B1 Process for production of piperidine derivatives |
| 09/03/2003 | EP0772447B1 Chinese herbs extract |
| 09/03/2003 | EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 09/03/2003 | EP0751780B1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 09/03/2003 | CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440402A N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2003 | CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides |
| 09/03/2003 | CN1440395A COLCHINOL derivatives as vascular damaging agents |
| 09/03/2003 | CN1440385A Pyrrole derivatives for treating AIDS |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1440295A Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol monno-oligosaccharide |
| 09/03/2003 | CN1440293A Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 09/03/2003 | CN1439641A Anti-cancer chemicals of methotrexate derivatives and their uses in pharmaceutical science |
| 09/03/2003 | CN1439428A Medical use and medicinal preparation of trichonema in preventing human and animals from diseases by immunologic inadequacy |
| 09/03/2003 | CN1439426A Medicine composition and preparation and use thereof |
| 09/03/2003 | CN1439423A Cordyceps sinensis buccal tablets |
| 09/03/2003 | CN1439412A Drug and preparation method for improvement of organismic immunity |
| 09/03/2003 | CN1120173C Antitumor substance extracted from Grifola |
| 09/03/2003 | CN1120160C Isoxazole and cortonamide derivatives and their use as pharmaceuticals and disgnositics |
| 09/03/2003 | CN1120157C Substituted quinoline-2-carboxylic acid amidesuand their preparation and their use as medicaments and intermediate products |
| 09/03/2003 | CN1120153C Novel 2,2'-Bi-1H-pyrrole derivatives with immunosuppressant activity |
| 09/03/2003 | CN1120005C Chinese medicinal preparation of irritable purpuric nephritis |
| 09/03/2003 | CN1120002C Application of ammonium nilrate in pharmaceutical industry, food and health-care product |
| 09/02/2003 | US6613926 Perchloramido phosphonyl reagents and analogs thereof |
| 09/02/2003 | US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/02/2003 | US6613912 Useful as drugs or protecting plants |
| 09/02/2003 | US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters |
| 09/02/2003 | US6613905 Chemokine receptor antagonists and methods of use therefor |
| 09/02/2003 | US6613882 Use for intracellular transport and membrane presentation of certain epitopes |
| 09/02/2003 | US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 09/02/2003 | US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors |
| 09/02/2003 | US6613774 Alkaloids used as immunosuppressants, antiproliferative or antitumor agents for therapy of autoimmune diseases or allergies |
| 09/02/2003 | US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands |
| 09/02/2003 | US6613769 Tryptase inhibitors |
| 09/02/2003 | US6613760 Indole derivatives and their use as MCP-1 receptor antagonists |
| 09/02/2003 | US6613739 Immunosuppressants |
| 09/02/2003 | US6613333 Immunodominant human T-cell epitopes of hepatitis C virus |
| 09/02/2003 | US6613330 Methods and compositions for preventing anti-Gal production in xenograft recipients |
| 09/02/2003 | US6613322 Administering enzyme inhibitors |
| 09/02/2003 | US6613321 Strain is unable to express homologous O-polysaccharide due to a 1.2 kb deletion that spans the junction of the rfbA and rfbB genes, and expresses a heterologous O-polysaccharide that is covalently linked to a lipopolysaccharide |
| 08/28/2003 | WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 08/28/2003 | WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |